ropivacaine has been researched along with Post-Dural Puncture Headache in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony Cometa, M; Smith, CR; Zasimovich, Y | 1 |
| Durán, FJ; Godinho, PM; Gonçalves, LM; Valente, EC | 1 |
2 other study(ies) available for ropivacaine and Post-Dural Puncture Headache
| Article | Year |
|---|---|
Percutaneous sphenopalatine ganglion block: an alternative to the transnasal approach.
Topics: Humans; Post-Dural Puncture Headache; Ropivacaine; Sphenopalatine Ganglion Block | 2021 |
Sphenopalatine ganglion block by transnasal approach in post-dural puncture headache.
Topics: Administration, Intranasal; Adult; Analgesia, Obstetrical; Anesthesia, Epidural; Anesthetics, Local; Female; Humans; Post-Dural Puncture Headache; Ropivacaine; Sphenopalatine Ganglion Block; Treatment Outcome | 2018 |